A Case of Erythroderma Secondary to Hypereosinophilia

Hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterised by marked peripheral eosinophilia and end organ damage attributable to eosinophilia without secondary cause. Early recognition and treatment are essential to prevent morbidity and mortality. Cytoreduction with Steroids,...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of clinical and diagnostic research Vol. 10; no. 5; pp. OD15 - OD16
Main Authors:	Abdulsalam, Mohammed Shafi, Ghanta, Hari Chandana, Pandurangan, Prabu, Menon, Maya, Jacob, Sheba S K
Format:	Journal Article
Language:	English
Published:	India JCDR Research and Publications Private Limited 01-05-2016
Subjects:	adrenal insufficiency cytoreduction lymphangioma of spleen tissue eosinophilia Cytoreduction Lymphangioma of spleen Adrenal insufficiency Tissue eosinophilia
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Hypereosinophilic syndrome (HES) is a myeloproliferative disorder characterised by marked peripheral eosinophilia and end organ damage attributable to eosinophilia without secondary cause. Early recognition and treatment are essential to prevent morbidity and mortality. Cytoreduction with Steroids, Hydroxyurea and Imatinib are the main stay of treatment. Molecular studies like Fip1-like-1 fused with platelet derived growth factor receptor alpha (FIP1L1-PDGFRα) etc., are recommended in view of therapeutic implication. In this paper we report a rare case of HES developing in a lady 6 months after surgical removal of lymphangioma of spleen, which in itself is rare.
ISSN:	2249-782X 0973-709X
DOI:	10.7860/JCDR/2016/19057.7770